tiprankstipranks
Trending News
More News >
Glow LifeTech (TSE:GLOW)
:GLOW

Glow LifeTech (GLOW) AI Stock Analysis

Compare
4 Followers

Top Page

TSE:GLOW

Glow LifeTech

(GLOW)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 4o)
Rating:58Neutral
Price Target:
C$0.06
▼(-5.00% Downside)
Glow LifeTech's overall score is driven by positive corporate events that enhance its financial position and growth outlook. However, ongoing profitability challenges and valuation concerns moderate the score. Technical indicators provide a neutral to slightly positive outlook.
Positive Factors
Revenue Growth
Strong revenue growth indicates expanding market presence and product demand, which can enhance long-term financial performance and market share.
Business Model
The direct-to-consumer model allows for better margin control and customer engagement, supporting sustainable revenue streams and competitive positioning.
Low Debt Levels
Low debt levels provide financial flexibility and reduce risk, allowing the company to invest in growth opportunities without significant leverage concerns.
Negative Factors
Profitability Challenges
Ongoing losses and negative profit margins indicate operational inefficiencies, which could hinder long-term financial sustainability and investor confidence.
Cash Flow Issues
Persistent negative cash flow can strain resources and limit the company's ability to invest in growth, impacting its long-term operational viability.
Negative Equity Returns
Negative equity returns suggest that the company is not generating sufficient returns on shareholder investments, which could affect future capital raising efforts.

Glow LifeTech (GLOW) vs. iShares MSCI Canada ETF (EWC)

Glow LifeTech Business Overview & Revenue Model

Company DescriptionGlow LifeTech (GLOW) is a cutting-edge biotechnology firm specializing in the development of innovative health and wellness products that harness the power of natural ingredients and advanced technology. The company operates primarily in the health and wellness sector, focusing on creating supplements, skincare solutions, and wellness devices aimed at enhancing overall well-being. With a commitment to sustainability and efficacy, GLOW leverages scientific research to formulate products that meet the evolving needs of health-conscious consumers.
How the Company Makes MoneyGlow LifeTech generates revenue through multiple streams, primarily from the sale of its health supplements and skincare products through both online and offline retail channels. The company operates a direct-to-consumer e-commerce platform, which allows it to capture higher margins by selling directly to customers. Additionally, GLOW has established partnerships with various health and wellness retailers, providing its products in physical stores and expanding its market reach. The company also engages in subscription-based models for certain product lines, ensuring consistent revenue flow. Furthermore, GLOW invests in research and development to innovate new products, which can lead to increased sales and market share, thereby enhancing its financial performance.

Glow LifeTech Financial Statement Overview

Summary
Glow LifeTech shows strong revenue growth but continues to face profitability challenges with significant net losses and negative equity returns. The balance sheet is supported by a low debt-to-equity ratio, but cash flow issues persist, indicating a need for improved operational efficiency.
Income Statement
35
Negative
Glow LifeTech has shown significant revenue growth of 51.4% in the latest year, which is a positive indicator. However, the company is still operating at a loss with a negative net profit margin of -317.75% and negative EBIT and EBITDA margins. The high gross profit margin of 70.68% suggests potential for profitability if operational efficiencies improve.
Balance Sheet
40
Negative
The company's debt-to-equity ratio is relatively low at 0.16, indicating manageable debt levels. However, the negative return on equity of -103.37% highlights significant losses relative to shareholder equity. The equity ratio of 69.06% suggests a strong equity base compared to total assets, but overall financial health is weakened by persistent losses.
Cash Flow
30
Negative
Glow LifeTech's cash flow situation remains challenging with negative operating cash flow and free cash flow. The free cash flow to net income ratio is slightly positive at 1.01, indicating that free cash flow covers net income losses. However, the negative operating cash flow to net income ratio reflects ongoing cash burn issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.85M836.19K43.93K0.000.000.00
Gross Profit957.52K591.00K-759.18K-263.26K-43.39K0.00
EBITDA-973.91K-1.24M-1.31M-1.92M-4.59M-153.00K
Net Income-2.28M-2.66M-1.59M-2.24M-11.31M-153.00K
Balance Sheet
Total Assets3.70M3.72M1.91M2.31M3.76M2.60K
Cash, Cash Equivalents and Short-Term Investments1.12M1.29M34.0075.19K746.02K1.80K
Total Debt435.15K404.08K171.75K147.36K39.93K6.40K
Total Liabilities1.48M1.15M2.35M1.14M328.03K315.57K
Stockholders Equity2.22M2.57M-433.12K1.16M3.44M-312.97K
Cash Flow
Free Cash Flow-422.96K-1.36M-490.86K-1.36M-3.62M-18.65K
Operating Cash Flow-372.69K-1.35M-417.26K-1.30M-3.18M-18.65K
Investing Cash Flow-51.98K16.70K-60.91K18.31K-541.41K-1.36K
Financing Cash Flow657.99K2.62M445.01K491.44K4.59M2.93K

Glow LifeTech Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.06
Price Trends
50DMA
0.05
Positive
100DMA
0.05
Positive
200DMA
0.06
Positive
Market Momentum
MACD
<0.01
Negative
RSI
53.73
Neutral
STOCH
133.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GLOW, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.05, and above the 200-day MA of 0.06, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.73 is Neutral, neither overbought nor oversold. The STOCH value of 133.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:GLOW.

Glow LifeTech Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
58
Neutral
C$9.96M-4.04-153.85%239.98%39.01%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
C$14.60M-1.80-3.93%-575.24%
44
Neutral
C$5.86M-2.87
29
Underperform
$6.41M-0.9925.09%
21
Underperform
C$7.59M-8.3385.61%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:GLOW
Glow LifeTech
0.06
0.00
0.00%
TSE:IOT
Innovotech
0.27
0.09
50.00%
TSE:KNE
Kane Biotech
0.04
-0.06
-60.00%
TSE:BLAB
Britannia Life Sciences Inc
0.09
<0.01
12.50%
TSE:BETR
BetterLife Pharma
0.05
-0.06
-54.55%
TSE:BIOV
BioVaxys Technology
0.22
-0.28
-56.00%

Glow LifeTech Corporate Events

Business Operations and StrategyFinancial Disclosures
Glow Lifetech Achieves Record Q3 2025 Results and Positive Cash Flow
Positive
Nov 25, 2025

Glow Lifetech Corp. reported a record-breaking Q3 2025 with a 193% year-over-year revenue growth and achieved its first positive cash flow from operations. This milestone reflects the company’s strong commercial momentum, disciplined cost management, and improved financial strength, positioning it for continued growth and profitability. The company expanded its market presence by adding new listings with major retailers in Ontario and launching products in Saskatchewan, while maintaining its leadership in the oils category with its MOD™ brand. Glow’s strategic focus on product innovation and national expansion supports its long-term growth trajectory into 2026.

Business Operations and StrategyFinancial Disclosures
Glow Lifetech Achieves Debt-Free Status, Strengthens Financial Position
Positive
Nov 19, 2025

Glow Lifetech Corp has achieved a debt-free status, marking a significant milestone in its financial management strategy. By eliminating over $1.4 million in debt, the company has strengthened its balance sheet, reduced interest expenses, and enhanced its financial flexibility, positioning itself for sustainable long-term growth and profitability. This financial achievement allows Glow to focus on advancing its national growth strategy and scaling its category-leading brands, thereby creating long-term value for shareholders.

Private Placements and FinancingBusiness Operations and Strategy
Glow Lifetech Enhances Financial Structure with Warrant Exercise and Debt Settlement
Positive
Oct 28, 2025

Glow Lifetech Corp. has strengthened its financial position by exercising over 9 million warrants, generating $452,500, and allowing over 11 million warrants to expire, reducing potential dilution and simplifying its capital structure. These actions, along with settling $50,000 in debt through share issuance, enhance Glow’s financial flexibility and support its strategic growth initiatives.

Product-Related AnnouncementsPrivate Placements and FinancingBusiness Operations and Strategy
Glow Lifetech Expands Nationally with Key Retail Partnerships and Strengthens Financial Position
Positive
Oct 20, 2025

Glow Lifetech Corp. has announced significant commercial growth with the expansion of its MOD™ products into over 60 One Plant cannabis stores across Ontario and Saskatchewan. This strategic partnership with One Plant, a leading Canadian cannabis retailer, enhances Glow’s national distribution and positions the company for future growth opportunities. Additionally, Glow has successfully completed its first shipment to Saskatchewan, marking its entry into Western Canada with 10 product listings across its MOD™ and .decimal™ brands. To support its growth initiatives, Glow is also strengthening its financial position by settling outstanding debt through the issuance of common shares, preserving cash for working capital.

Business Operations and Strategy
Glow Lifetech Expands into Saskatchewan, Strengthening National Growth Strategy
Positive
Sep 16, 2025

Glow Lifetech Corp. has announced the expansion of its MOD™ and .decimal™ brands into the Saskatchewan cannabis retail market, marking a significant step in its national growth strategy. This expansion into Western Canada is part of Glow’s broader strategy to scale its operations across the country by leveraging its success in Ontario. The company aims to deepen its market penetration in Ontario while strategically entering new provinces, reflecting its disciplined growth strategy and positioning it for sustainable growth and long-term value creation.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025